Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
131.9 USD | +0.11% | +6.50% | +20.76% |
03:02pm | Merck: new indication approved for Keytruda in Europe | CF |
01:45pm | Merck Says Keytruda Plus Chemotherapy as Neoadjuvant Treatment Receives Approval From European Commission | MT |
- Stock
- Equities
- Stock Merck & Co., Inc. - Nyse
- News Merck & Co., Inc.